No Detail Found!

Caveats of Prostate Cancer Diagnosis: Diagnostic Utility Study of Digital Rectal Examination, Prostate Volume and Prostate Specific Antigen.

Author(s)
Ashfaq Ur Rehman Department of Urology, Lady Reading Hospital, Peshawar – Pakistan
Ikram Ullah Khattak Department of Urology, Lady Reading Hospital, Peshawar – Pakistan
MirAlam Jan Department of Urology, Lady Reading Hospital, Peshawar – Pakistan
Bilal Ahmad Department of Urology, Lady Reading Hospital, Peshawar – Pakistan
Abstract
Objective: To investigate the diagnostic utility of prostate specific antigen (PSA), digital rectal examination (DRE) and prostate volume (PV) in arriving at diagnosis of prostate cancer (PCa) in a cohort of elderly male patients presenting with lower urinary tract symptoms (LUTS). Methodology: This was a descriptive study of 120 elderly (> 50-years-old) male patients who presented with complaints of LUTS or were referred for further specialist management. All patients were s subjected to DRE on clinical examination, PV assessment on ultrasonography and a PSA screen. Prostate biopsy reports were recorded (positive or negative for PCa) once the patient underwent prostatectomy (transvesical prostatectomy-TVP, transurethral resection of prostate-TURP or transrectal prostate biopsy-TRPB). Results: There were 120 patients with overall mean age of 71.03 ±9.19 years. Combining the three test variables, namely DRE, PV and PSA, the sensitivity was 61.8%, specificity was 70.8%, positive predictive value was 64.1% and negative predictive value was 68.7%. The most effective single test was DRE if applied alone, and the most ineffective was PSA if considered alone for diagnosing PCa. Patients with a positive DRE had 5.45 while raised PSA had 1.01 times higher odds to exhibit PCa as those having a negative DRE or a lower PSA. However, an increasing PV had no significant effect on the likelihood (OR =0.96, 95% CI, 0.928 to 1.008) of having a diagnosis of PCa. Conclusion: A combination of the DRE, PV and PSA has good diagnostic capacity and should be used to better identify prostate cancer patients.
Publication Details
Page(s) 211-215
DOI DOI not available
Published Journal: Journal of Postgraduate Medical Institute, Volume: 32, Issue: 2, Year: 2018

Request the full text from PASTIC

References
ScherHI,SoloK,ValantJ,ToddMB,MehraM.,,2015,Prevalence of prostate cancer clinical states and mortality in the united states: Estimates using a dynamic progression model,PLoS One,10,e0139440-
SiegelRL,MillerKD,JemalA,,2015,,CA Cancer J Clin,65,5-29
HowreyBT,KuoYF,LinYL,GoodwinJS,,2013,The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States,J Gerontol A Biol Sci Med Sci,68,56-61
FarkasA,MarcellaS,RhoadsGG,,2000,Ethnic and racial differences in prostate cancer incidence and mortality,Ethn Dis,10,69-75
FerlayJ,SoerjomataramI,DikshitR,EserS,MathersC,RebeloM,,2015,Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,Int J Cancer,136,E359-86
AraiY,MaedaH,IshitoyaS,OkuboK,OkadaT,AokiY.,,1997,Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels,J Urol,158,861-4
WalshAL,ConsidineSW,ThomasAZ,LynchTH,ManeckshaRP,,2014,Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study,Br J Gen Pract,64,e783-7
HattangadiJA,ChenMH,D'Amico AV,,2012,Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death,BJU Int,110,1636-41
ClementsR,PenneyMD,EtheringtonRJ,GriffithsGJ,HughesH,PeelingWB,,1992,Volume of normal prostate, of prostate cancer, and of benign prostatic hyperplasia: are correlations with prostate specific antigen clinically useful?,Prostate Suppl,4,51-7
AzizDC,BarathurRB,,1993,Prostate-specific antigen and prostate volume: a meta-analysis of prostate cancer screening criteria,J Clin Lab Anal,7,283-92
ParkJY,YoonS,ParkMS,ChoDY,ParkHS,,2011,Initial biopsy outcome prediction in Korean patients-Comparison of a Noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing,J Korean Med Sci,26,85-91
ShafiqueK,MorrisonDS,,2013,Socio-economic inequalities in survival of patients with prostate cancer: Role of age and Gleason grade at diagnosis,PLoS ONE,8,e56184-
GoovaertsP,XiaoH,,2011,Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis,Int J Health Geogr,10,63-
MalatiT,KumariGR,,2004,Racial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian males,Indian J Clin Biochem,19,132-7
DubeyD.,,2009,The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?,Indian J Urol,25,177-84
JeongCW,ParkHK,HongSK,ByunSS,LeeHJ,LeeSE,,2008,Comparison of prostate volume measured by transrectal ultrasonography and MRI with the actual prostate volume measured after radical prostatectomy,Urol Int,81,179-85
AlaneeS,MooreA,NuttM,HollandB,DyndaD,El-ZawahryA,,2015,,Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer. Anticancer Res,35,4145-50
BrayF,Lortet-TieulentJ,FerlayJ,FormanD,AuvinenA,,2010,Prostate cancer incidence and mortality trends in 37 European countries: an overview,Eur J Cancer,46,3040-52
AhnJH,LeeJZ,ChungMK,HaHK,,2014,Nomogram for prediction of prostate cancer with serum prostate specific antigen less than 10 ng/mL,J Korean Med Sci,29,338-42
KimYM,ParkS,KimJ,ParkS,LeeJH,RyuDS,,2013,Role of prostate volume in the early detection of prostate cancer in a cohort with slowly increasing prostate specific antigen,Yonsei Med J,54,1202-6
HolmströmB,JohanssonM,BerghA,StenmanUH,HallmansG,StattinP,,2009,Prostate specific antigen for early detection of prostate cancer: longitudinal study,Br Med J,339,b3537-
YuHJ,LaiMK,,1998,The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer,Urology,51,125-30
0

Citations

0

Downloads

95

Views